Diabetes News and Research

Latest Diabetes News and Research

FDA accepts Genzyme’s LEMTRADA sBLA for review

Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).

28 Jan 2013

New AngioSculpt catheters from AngioScore can treat peripheral artery disease below the knee

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).

28 Jan 2013

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

28 Jan 2013

Research roundup: Does higher Rx drug spending lower Medicare costs?; Price transparency doesn't affect radiological decisions

Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.

28 Jan 2013

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.

28 Jan 2013

Low income impacts on diabetes incidence in Ontario

Canadian researchers have found that diabetes incidence is inversely related to income in the province of Ontario.

25 Jan 2013

Undetected comorbidities linked to increased mortality in schizophrenia

Patients with schizophrenia have elevated mortality, the leading causes of which appear to be ischemic heart disease and cancer, a Swedish national cohort study shows.

25 Jan 2013

Weekly aspirin may increase AMD risk

People who take aspirin more than once per week may be at increased risk for developing neovascular age-related macular degeneration, a prospective study has found.

25 Jan 2013

New evidence supports thrombolysis in presence of contraindications

A Norwegian study offers further evidence to support the use of intravenous thrombolysis to treat stroke even in patients with contraindications to the drug.

25 Jan 2013

Antibiotic use common at the end of life

More than one-quarter of hospice patients receive antibiotics in their last week of life, despite the absence of documented infection in most cases, US researchers report.

25 Jan 2013

Botox relieves plantar fasciitis pain

Botulinum toxin A may be more effective than steroids for the treatment of plantar fasciitis, research suggests.

25 Jan 2013

Lasting impact of fetal valproate exposure

Fetal exposure to the antiepileptic drug valproate has a dose-dependent negative impact on children’s IQ at age 6 years, shows a study in The Lancet Neurology.

25 Jan 2013

Simple urine test picks up mesalamine non-adherence

A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows.

25 Jan 2013

Efficacy of docusate called into question

Docusate does not significantly improve the management of constipation in hospice patients, show the results of a randomized, placebo-controlled trial.

25 Jan 2013

HDL cholesterol key to fighting lymphoma

High-density lipoprotein cholesterol could provide a novel treatment target for patients with lymphoma, US scientists believe.

25 Jan 2013

‘Imperfect’ test for misplaced epidural catheter studied

A reduced dose of lidocaine may have advantages over a standard dose for detecting inadvertent intrathecal catheter placement during epidural anesthesia, but neither is wholly reliable, say researchers.

25 Jan 2013

One more reason to quit smoking

Smokers who quit when they are young adults can live almost as long as people who never smoked, groundbreaking new research has found.

25 Jan 2013

Findings could help develop targeted exercise for obese women with Type 2 diabetes

More than one-third of Americans are obese, and these individuals often experience accompanying health issues, such as Type 2 diabetes and cardiovascular problems. In response to the so-called "obesity epidemic," many medical professionals have suggested ways to improve the health outcomes of obese individuals through diet and exercise.

25 Jan 2013

Reuters reports on obesity talks at World Economic Forum

Reuters reports on discussions taking place at the World Economic Forum (WEF), taking place in Davos, Switzerland, this week, writing, "Obesity, a major factor in diabetes and heart disease, imposes costs on both public and private sectors and is a drag on economic growth, but business leaders meeting in Davos can't agree on what they can or should do to address it."

25 Jan 2013

Kidney disease increases risk of premature death in diabetic patients

One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. It may be possible to live a long and healthy life with diabetes, but once kidney disease develops, the risk of dying prematurely increases significantly, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

25 Jan 2013

Diabetes News and Research

Latest Diabetes News and Research

FDA accepts Genzyme’s LEMTRADA sBLA for review

New AngioSculpt catheters from AngioScore can treat peripheral artery disease below the knee

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Research roundup: Does higher Rx drug spending lower Medicare costs?; Price transparency doesn't affect radiological decisions

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

Low income impacts on diabetes incidence in Ontario

Undetected comorbidities linked to increased mortality in schizophrenia

Weekly aspirin may increase AMD risk

New evidence supports thrombolysis in presence of contraindications

Antibiotic use common at the end of life

Botox relieves plantar fasciitis pain

Lasting impact of fetal valproate exposure

Simple urine test picks up mesalamine non-adherence

Efficacy of docusate called into question

HDL cholesterol key to fighting lymphoma

‘Imperfect’ test for misplaced epidural catheter studied

One more reason to quit smoking

Findings could help develop targeted exercise for obese women with Type 2 diabetes

Reuters reports on obesity talks at World Economic Forum

Kidney disease increases risk of premature death in diabetic patients

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in